News

Media And Political Bulletin – 05 March 2020

Media and Political Bulletin

05 March 2020

Media Summary

Hub and spoke dispensing Bill progresses

Dispensing Doctors’ Association, Ailsa Colquhoun, 05 March 2020

Dispensing Doctors’ Association reports that hub and spoke dispensing by independent pharmacies is a step closer to becoming reality following the second reading of the Medicines and Medical Devices Bill. Other aspects of the Bill, which is broadly supported by opposition MPs and which has passed without division, include the following:

  • New provisions for digital pharmaceutical labelling
  • Legislation relating to the safety of online pharmacies
  • Legislation covering medicine brokerage
  • Increase non-medical prescribing
  • Create a UK register of medical devices

‘Brexit buffer’ of medicines mean UK is ‘well prepared’ for coronavirus

LBC, 04 March 2020

LBC reports that as the number of cases of coronavirus grows within the UK and worldwide concerns have been raised over potential shortages to vital medicines, the DHSC has said there are currently no drug shortages as a result of coronavirus.

They added that the country is well prepared to deal with any impacts of the coronavirus and there are stockpiles of generic drugs like paracetamol in the event of any supply issues.

Meanwhile, the Royal Pharmaceutical Society said that a “Brexit buffer” of medicines was stockpiled in the event of a no-deal Brexit, which means the UK is “well prepared” for any potential shortages.

 

 

Parliamentary Coverage

Patients asked to return Emerade 150 micrograms adrenaline pens

MHRA, 04 March 2020

Patients, or carers of patients, who carry Emerade 150 microgram auto-injector pens should return all in-date Emerade 150 micrograms auto-injectors to their local pharmacy once they have obtained a prescription for, and been supplied with, an alternative brand.

Recall action has been taken due to reports of difficulty in activating the Emerade pens, meaning a dose of adrenaline cannot be delivered. This defect also affects the 300 and 500 microgram strengths of Emerade adrenaline pens, which will be recalled when sufficient supplies of alternative brands (Epipen and Jext) are available.

Hormone Replacement Therapy: Shortages – Written question

Jonathan Ashworth (Leicester South): To ask the Secretary of State for Health and Social Care, with reference to the recommendation of 7 February 2020 by the Royal College of Obstetricians and Gynaecologists, if he will convene a working group with industry, regulatory agencies and professional bodies to tackle the HRT shortages.

Jo Churchill (answered on 04 March 2020): We are in regular discussions with the Royal College of Obstetricians and Gynaecologists about hormone replacement therapy (HRT) supply issues and are currently reviewing their proposal to convene a working group with industry, regulatory agencies and professional bodies to tackle this supply issue.

We continue to work with the Royal College as well as a number of other stakeholders including the National Health Service, the pharmaceutical industry, the Medicines and Healthcare products Regulatory Agency, the British Menopausal Society and the Facility of Sexual and Reproductive Healthcare to resolve HRT supply issues as quickly as possible. The overall supply situation will start to improve from the end of February 2020.

 

Full Coverage

Hub and spoke dispensing Bill progresses

Dispensing Doctors’ Association, Ailsa Colquhoun, 05 March 2020

Hub and spoke dispensing by independent pharmacies has taken a step closer to reality following the second reading of the Medicines and Medical Devices Bill.

Other aspects of the Bill, which is broadly supported by opposition MPs and which has passed without division, include the following:

  • New provisions for digital pharmaceutical labelling
  • Legislation relating to the safety of online pharmacies
  • Legislation covering medicine brokerage
  • Increase non-medical prescribing
  • Create a UK register of medical devices

Responding for the Opposition, Shadow Health Secretary Jon Ashworth called for a “robust and sophisticated mechanism to evaluate app-based healthcare for use in the NHS” and stated that at the Public Health Committee stage, his party would look to strengthen regulation relating to health apps. The Public Bill Committee is expected to report to the House by Thursday 23 April.

‘Brexit buffer’ of medicines mean UK is ‘well prepared’ for coronavirus

LBC, 04 March 2020

Health officials have said preparations for a no-deal Brexit mean the UK is “well prepared” to resolve any potential medicine shortages due to coronavirus.

As the number of cases of coronavirus grows within the UK and worldwide concerns have been raised over potential shortages to vital medicines.

Indian authorities have restricted the export of 26 medicines – including one of the world’s most commonly used pain relief medications, paracetamol.

But the Department for Health and Social Care (DHSC) said that there are currently no drug shortages as a result of coronavirus.

The body said there are stockpiles of generic drugs like paracetamol “in the event of any supply issues”.

Meanwhile, the Royal Pharmaceutical Society said that a “Brexit buffer” of medicines was stockpiled in the event of a no-deal Brexit, which means the UK is “well prepared” for any potential shortages.

“There are currently no medicine shortages as a result of Covid-19,” a DHSC spokeswoman said.

They added that the country is well prepared to deal with any impacts of the coronavirus and there are stockpiles of generic drugs like paracetamol in the event of any supply issues.

Sandra Gidley, president of the Royal Pharmaceutical Society, said: “The Government recently acknowledged that whilst there is little evidence to suggest that supply chains have been affected as a result of restrictions in movement in China, precautionary steps are being taken to help ensure supply to the UK remains uninterrupted.

“The Brexit buffer of medicines that was created in preparation for a no-deal means that the UK is well prepared for any potential medicine shortages and has been able to stockpile to maintain access to medicines.

“As far as individuals are concerned, buying extra medicines when they are not needed is never a good idea as it can contribute towards potential shortages. Talk to your pharmacist if you have any concerns about your medicines. They already manage various shortages of medicines on a daily basis and work hard to get patients the medicines they need to keep them well.”

Media And Political Bulletin – 05 March 2020

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?